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Disruption of apoptosis is considered as an important factor aiding tumorigenesis, and aberrant DNA methylation of apoptosis-
associatedgenescouldbeanimportantandsigniﬁcantmechanismthroughwhichtumorcellsavoidapoptosis.However,littleis
known about (1) the impact of methylation status of apoptosis-associated genes on the presence of apoptosis evasion
phenotype in glioma; and (2) the molecular mechanism governing the aberrant methylation of apoptosis-associated genes in
glioma. By analyzing human glioma biopsies, we ﬁrst show that low level of apoptosis in tumor is correlated with aberrant
methylation of the bcl-2, bax and XAF-1 genes, but not with the aberrant methylation of the bcl-w, survivin, TMS1, caspase-8 and
HRK genes. Our work also indicates that the expression levels of DNA methyltransferase 1 (Dnmt1), Dnmt3b and Dnmt1/Dnmt3a
coregulate the methylation status of survivin, TMS1 and caspase-8, whereas no correlation was observed between the
expression level of Dnmts and the methylation status of the bcl-w, bcl-2, bax, XAF-1 and HRK genes. Thus, these resultsindicate
that the epigenetic regulation of some apoptosis-regulated genes could dictate whether glioma harbors the apoptosis evasion
phenotype,andprovidesomebasestotheidentiﬁcationofthemethylationmachineriesofapoptosis-associatedgenesforwhich
the Dnmt expression acts as a limiting factor.
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Apoptosis or programmed cell death has a crucial role in the
maintenance of cellular homeostasis, that is, a balance
between cell proliferation and cell death. During tumorigen-
esis, there is an enhanced ability of the cells to survive in the
face of death-inducing mechanisms. Besides, evasion of
apoptosis is considered as one of hallmarks characterizing
cancer cells.
1 Cancer cells are known to avoid apoptosis by a
numberofmechanisms,whichincludelossoffunctionoftumor
suppressor genes though mutations, increased expression of
antiapoptotic proteins, expression of oncogenes, increased
levels of prosurvival signals, functional inactivation of the
members involved in apoptotic signaling, defects in execution
pathwaysofapoptosisandviral-mediatedinactivationoftumor
suppressor proteins though the interaction of viral protein.
1
Evidence from literature indicates that DNA methylation-
mediated regulation of genes involved in apoptosis could be a
signiﬁcant mechanism through which tumor cells avoid
apoptosis.
2 Indeed, evasion of apoptosis can be due to
changes in methylation patterns. These changes can occur
either inthe formofhypomethylation toreactivate antiapoptotic
genes or hypermethylation to repress proapoptotic genes.
2
In the ﬁrst part of the present report, we have analyzed
whether the global DNA methylation status is associated with
a phenotype of apoptosis evasion of glioma and whether this
phenotype could be explained by the methylation status of
eight apoptosis-associated genes. In the second part of this
report, we have analyzed whether the methylation status of
eight apoptosis-associated genes is directly correlated with
the expression levels of DNA methyltransferases (Dnmt), that
is, with the expression levels of enzymes catalyzing the DNA
methylation of mammalian genes.
3,4 Indeed, the etiology of
aberrant DNA methylation status of apoptosis-regulated
genes is not fully elucidated. Except for the participation of
Dnmt1 and of Dnmt3b4/2, a member of the Dnmt3b subfamily
of proteins, in the methylation machinery of survivin and
RASSF1A genes, no link is clearly established between the
methylation of apoptosis-associated genes and Dnmt.
3,4
Thus, the results of these interrogations could provide the
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Results
Methylation status of apoptosis-regulated genes in
glioblastoma multiforme. As glioblastoma multiforme
(GBM) is known to avoid apoptosis and to present a global
DNA hypomethylation pattern, we have searched whether
these two parameters can constitute predictive factors of
glioma progression.
1,5,6 For this purpose, we assessed
the DNA methylation status through the quantiﬁcation of
5-methylcytosine (5mC) number present on DNA using an
ELISA method. The phenotype of apoptosis evasion was
estimated based on the measure of intra-tumor apoptosis
level through quantiﬁcation of caspase activity (referred to as
DEVDase activity), because caspase/DEVDase are ﬁnal
effectors of cell death program. For each parameter, 27
patients were divided into 2 groups based on the 5mC level
or on the level of DEVDase activity found on their tumor
biopsies. Survival curves were estimated by Kaplan–Meier
method and compared by using the Cox proportional hazards
survival regression analysis. Thus, signiﬁcant difference was
observed between patients whose tumors had high level of
5mC and those whose tumors did not, and between patients
whose tumors had high level of DEVDase activity and those
whose tumors did not (P¼0.0113 and P¼0.0466,
respectively) (Figure 1a and b). In other terms, these
results indicate that the low level of 5mC and the low level
of DEVDase activity are two poor prognosis factors.
We then continued our study by searching whether these
two parameters are correlated. A statistical analysis using
Pearson’s correlation test showed a signiﬁcant correlation
between thesetwo parameters in GBM: low DEVDase activity
is correlated with low 5mC number (r¼0.4161, P¼0.0309)
(Figure 1c). Moreover and as expected, Kaplan–Meier and
Cox proportional hazards survival regression analyses
associated the copresence of low 5mC number and low
DEVDase activity in tumors with the weak survival of patients
whose tumors had these two hallmarks (Figure 1d). Thus, all
these results suggest that the DNA methylation could have a
crucial role in the disruption of execution of cell death program
in GBM. Consistently, some reports have already described
that apoptosis-associated genes can be epigenetically
regulated in glioma.
7–13
To study the impact of methylation-induced disruption of
the execution of apoptosis, we have decided to examine the
methylation status of eight genes encoding for proteins
regulating the apoptotic program in a collection of 27 GBM
patients (Figure 2a). The eight genes chosen were (1)
caspase-8 gene encodes for an initiator caspase, which is
characterized by the presence of two homotypic interaction
motifs called DEDs (death-effector domains). Caspase-8
cleaves Bid to generate truncated Bid, which activates
proapoptotic proteins Bax and Bak to promote apoptosis
through the cytochrome c release from the mitochondria and
caspase-3 activation. Caspase-8 can also directly activate
effector caspases such as caspase-3; (2) TMS1 gene (target
for methylation-induced silencing-1 or apoptosis-associated
speck-like protein containing CARD – ASC) encodes for a
protein consisting of PYD (pyrine domain) and CARD motifs.
TMS1/ASC has been shown to induce apoptosis in a
caspase-8-dependent manner;
14 (3–4) bcl-w and bcl-2 genes
encode for two antiapoptotic proteins characterized by the
presence of all BH1–4 domains. Antiapoptotic proteins block
apoptotic program by inhibiting the proapoptotic proteins such
as Bax;
15 (5) HRK gene encodes for the proapoptotic protein
HRK (harakiri), which belongs to the BH3-only protein family
and selectively antagonizes the antiapoptotic proteins Bcl-2
and Bcl-xl;
16 (6) bax gene encodes for the p21 bcl-associated
X-protein or Baxa. Baxa induces the release of cytochrome c
from the mitochondria, activation of caspase-3 and thereby
apoptosis;
17 (7) survivin gene encodes for an antiapoptotic
protein characterized by the presence of the Baculoviral
inhibitor of apoptosis protein repeat (BIR) motif, which also
characterized the Inhibitor of Apoptosis Proteins (IAPs).
Survivin can inhibit apoptosis by binding and blocking the
activation of caspase-3;
18 (8) XAF-1 gene encodes for the X-
linked inhibitor of apoptosis-associated factor-1 (XAF-1).
XAF-1 negatively regulates X-linked inhibitor of apoptotsis
(XIAP), a member of the IAP family (XIAP, c-IAP-1 and c-IAP-
2), which are potent inhibitors of caspase-3, -7 and -9.
19
Methylation-speciﬁc PCR (MSP) was used to determine the
methylation status of these eight genes, according to the
primers designed by using the MethPrimer program (Supple-
mentary Figure S1).
20 With respect to the bax gene, we
distinguished two methylation proﬁles. The ﬁrst, named
bax
Baxc, is associated with Baxc expression, and the second,
referred to as bax
silencing, is correlated with the bax gene
silencing.
7,8 MSP showed that methylation of bcl-w, bcl-2,
bax
silencing, bax
Baxc, survivin, XAF-1, TMS1, caspase-8 and
HRK genesoccurs witha frequencyof19,22, 4, 19,30,22,48,
30 and 30% in our collection of 27 GBM patients (Figure 2b).
On the basis of these results, we next determined whether
the methylation of these genes confers a poor prognosis
in GBM patients. Survival curves were estimated by Kaplan–
Meier method and compared by using the Cox proportional
hazards survival regression analysis. Thus, signiﬁcant differ-
ence was observed between patients whose tumors had the
bax
BAXc methylation proﬁle and those whose tumors did not
(P¼0.0044), whereas no signiﬁcant difference was observed
for the methylation proﬁle of other considered genes (bcl-w,
P¼0.6690, bcl-2, P¼0.3437; survivin, P¼0.4328; XAF-1,
P¼0.2986; TMS1, P¼0.4379; caspase-8, P¼0.116 and
HRK, P¼0.2759) (Figure 2c). The presence of the bax
silencing
methylation proﬁle confers short survival time to the patient
harboringthishallmark(3.1months).However,thispointmust
be conﬁrmed with more samples.
We then complemented this study by analyzing whether the
unmethylation of genes coding for proapoptotic proteins and the
methylation of genes coding for antiapoptotic proteins could
collectively confer a good prognosis for GBM patients. For this
purpose, we calculated the score of methylation of apoptosis-
associated genes. A value of þ1 was attributed to each tumor
harboring the methylated gene coding for an antiapoptotic
protein or the unmethylated gene coding for a proapoptotic
protein. Avalueof 1wasattributedtoeachtumorharboringthe
unmethylated gene coding for an antiapoptotic protein or the
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Cell Death and Diseasemethylated gene coding for a proapoptotic protein. With respect
to the bax gene, þ1 was attributed when the bax
BAXc
methylation proﬁle was observed, and  1 was attributed when
the bax
silencing methylation proﬁle was observed. Thus, 11
tumors had a positive score (group no. A), that is, a score
potentially associated with the responsiveness of apoptosis,
whereas 16 tumors harbored a negative or null score (group no
B), that is, a score potentially associated with the apoptosis
escape phenotype. Besides, these points were supported by the
presence of a signiﬁcant correlation existing between the
methylation score and the DEVDase activity of each tumors
(Figure 2d). Survival curves of these two groups were estimated
by Kaplan–Meier method, and the Cox proportional hazards
survival regression analysis revealed that the presence of
negative or null score of methylation status of the considered
apoptosis-associated genes confers poor prognosis of GBM
patients (Figure 2d).
All these results conﬁrm that the presence of the bax
BAXc
methylation proﬁle is associated with a good prognosis in
GBM patients, and show that the methylation score of
apoptosis-associatedgenescanalsoconferagoodprognosis
in GBM patients, despite the fact the methylation status of
these genes is not individually a prognosis factor.
7
Low level of DNA methylation was associated with the
unmethylation of bcl-w, bcl-2 and survivin genes. We
next complemented our study by analyzing whether the
methylation status of these genes was correlated with the
global DNA methylation status. For this purpose, the 5mC
number and the methylation status of each gene were plotted
against each other, and statistical analyses using the
Pearson’s correlation test showed a correlation between
the low level of 5mC number on DNA and the unmethylation
of the bcl-w, bcl-2 and survivin genes (r¼0.5507,
P¼0.0029; r¼0.7521, Po0.0001; and r¼4467, P¼0.0195,
respectively) (Figure 3). These ﬁndings suggests that the
unmethylation of antiapoptotic genes, such as bcl-w, bcl-2
and survivin, occurring in a context of low genome
methylation could be because of many molecular causes
conferring the apoptosis evasion phenotype seen in glioma.
The bcl-2 gene unmethylation and/or the methylation of
XAF-1 and bax
Baxw genes inﬂuence the intra-tumor
apoptosis level. Consistent with the previous hypothesis,
we next investigated whether the methylation status of these
genes was correlated with the levels of intra-tumor apoptosis.
Thus, the methylation status of each gene and DEVDase
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Figure1 5-methylcytosine(5mC)numberandtheDEVDaseactivityinhumanGBM.(a,b)Kaplan–Meierestimatesoftimetosurvivalinfunctionof5mCnumberoroflevel
of DEVDase activity. The 5mC number was assessed with the Methylamp Global DNA methylation quantiﬁcation kit (Euromedex-Epigentek). DEVDase activity, representing
the activation level of the main effective caspases of apoptosis, was measured as previously described.
37 High: patients whose tumors are characterized by a 5mC level or a
DEVDase activity higher than the median; low: patients whose tumors are characterized by a 5mC level or a DEVDase activity equal to or lower or than the median. (c)
Correlation between the 5mC and the DEVDase activity in human GBM. Black area (#1) regroups patients whose tumors are characterized by the copresence of a low 5mC
number and a low level of DEVDase activity. (d) Kaplan–Meier estimates of time to survival in function of the copresence or not of a low 5mC number and a low level of
DEVDase activity in glioma. #1 represent the group of patients whose tumors are characterized by the copresence of a low 5mC number and a low level of DEVDase activity
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Cell Death and Diseaseactivity were plotted against each other, and statistical
analysis using the Pearson’s correlation test was performed
to determine the presence of a signiﬁcant correlation
between these parameters. As illustrated by the Figure 4a
and Supplementary Figure S2, we noted that the methylation
of bcl-2 gene was correlated with the presence of high
DEVDase activity in GBM (r¼0.3866; P¼0.0464), whereas
no correlation was observed between the methylation of
the bcl-w or survivin genes and the DEVDase activity
(r¼0.1721, P¼0.3907 and r¼0.0468, P¼0.8167). Similar
experiments showed the presence of a close correlation
between the presence of the bax
Bac methylation proﬁle and
high level of DEVDase activity in GBM (r¼0.8047;
Po0.0001). The presence of methylated XAF-1 gene was
correlated with the presence of low DEVDase activity in GBM
(r¼0.3920; P¼0.0431). Although not being correlated with
the DEVDase activity, we noted that the presence of the
bax
silencing gene occurred in GBM presenting the lower level
of DEVDase activity. Finally, our study showed no correlation
between the methylation status of TMS1, caspase-8 or HRK
genes and the level of intra-tumor DEVDase activity
(r¼ 0.2525, P¼0.2039; r¼0.2008, P¼0.3152; r¼
 0.1796, P¼0.3700; and r¼0.1804, P¼0.3679). We then
complemented these data by observing that the methylation
of the bcl-2, bax
silencing and XAF-1 gene was correlated with
the silencing or the low expression of these genes
(Figure 4b). Taken together, these results suggest that the
methylation-dependent silencing or downregulation of bcl-2,
bax and XAF-1 genes has a crucial role in the execution of
apoptotic program in GBM.
To conﬁrm this point, we decided to mime the methylation-
dependent silencing or downregulation of bcl-2, bax and
XAF-1 genes by performing gene invalidation experiments.
The efﬁciency of invalidations has been monitored by western
blots,andprogrammedcelldeathwasestimatedbyDEVDase
activity. Consistent with what we have already published, we
ﬁrst noted that the invalidation of Bax was a sufﬁcient point to
promote resistance of apoptosis in glioma cells previously
sensitive to etoposide-induced apoptosis (Figure 4c).
8 Simi-
larly, our results indicated that siRNA-induced XAF-1-
deﬁciency was sufﬁcient to generate a low level of apoptosis
in glioma cells (Figure 4d). According to the antiapoptotic role
of Bcl-2, we noted that the shRNA-induced invalidation of
bcl-2 gene expression was sufﬁcient to increase the etoposide-
induced apopto-sensitivity of glioma cells (Figure 4e). Thus,
our data indicate that the loss or the weak expression of the
bcl-2, bax or XAF-1 genes induced by their aberrant
methylation or by their invalidation is due to many conditions
inﬂuencing the execution of apoptosis.
Correlation between the methylation status of apoptosis-
regulated genes and the Dnmt expression. To establish a
relation between the methylation status of the apoptosis-
regulated genes included in our study and the Dnmt
expression in GBM, we complemented our study by
analyzing the level of expression of Dnmt1, Dnmt3a and
Dnmt3b by ELISA, because these three Dnmts are the main
enzymes implicated in DNA methylation in mammals.
Pearson’s correlation test revealed that the methylation
status of caspase-8 gene was correlated with the Dnmt1 and
Dnmt3a expressions (Figure 5). Similar statistical analyses
also indicated that the methylation status of survivin was
correlated with Dnmt1 expression, whereas the methylation
status of TMS1 was correlated with the Dnmt3b expression
(Figure 5). No relevant correlation was revealed by the
Pearson’s correlation test in our collection of 27 GBM
patients between the Dnmt expression and the methylation
status of bcl-w, bcl-2, bax, XAF-1 and HRK genes
(Supplementary Figure S3).
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Figure 2 Impact of the methylation status of the HRK, XAF-1, survivin, bcl-w,
TMS1, bcl-2, caspase-8 and bax genes on survival time of patients with GBM. (a)
Schematic representation of apoptotic pathway. (b) Methylation status of the HRK,
XAF-1, survivin, bcl-w, TMS1, bcl-2, caspase-8 and bax genes in 27 human GBM
patients. Open box represent unmethylated gene and black box represents
methylated gene. (c) Kaplan–Meier estimates of time to survival of GBM patients in
function of the methylation status of the bcl-2 or bax genes. (d) Left: correlation
between the methylation score of the apoptosis-associated genes and the
DEVDase activity. Group #A deﬁnes tumors having a positive score, that is, a score
potentially associated with the responsiveness of apoptosis; group #B deﬁnes
tumorsharboringa negativeornullscore,thatis,ascorepotentiallyassociatedwith
the apoptosis escape phenotype. Right: Kaplan–Meier estimates of time to survival
in function of the membership of group #A or #B
Methylation regulation of apoptosis-associated genes
E Hervouet et al
4
Cell Death and DiseaseTo conﬁrm the role had by Dnmt3b on the establishment of
the methylation status of TMS1 gene, we ﬁrst analyzed whether
the overexpression of the enzyme could enhance the methyla-
tion of these genes through the de novo methylation property of
these enzymes. Comparing the U87 cells with the U87 cells
treated with pORF-Dnmt3b, we observed an increase in the
methylation status of TMS1 gene, whereas the methylation of
caspase-8 was unchanged under this condition (Figure 6a and
Supplementary FigureS4).After transformation of the U87 cells
withthepORF-Dnmt3a,wenotedanincreaseinthemethylation
status of caspase-8 gene, without change in the methylation
status of TMS1 gene (Figure 6b).
In parallel with these results, we also decided to conﬁrm the
correlation obtained from GBM by analyzing the impact of
Dnmt invalidation on the methylation status of caspase-8,
survivinandTMS1genesinU251cells.Dnmtinvalidationwas
monitored by qPCR and the methylation status of caspase-8,
survivinandTMS1geneswasmonitoredbyMethylationArray
and Methylated DNA Immunoprecitation (MeDIP) (Supple-
mentary Figure S5).
We thus noted that the single Dnmt1 invalidation in U251
cells abolished the methylation of caspase-8 gene and that
the single Dnmt3a invalidation decreased the methylation
status of this gene (Figure 6c). As expected, the single
invalidation of Dnmt1 affected the methylation status of
survivin gene by inducing a signiﬁcant hypomethylation
(Figure6d).Consistentwithourpreviousresults,weobserved
that the invalidation of Dnmt3b abolished the methylation
status of TMS1 gene (Figure 6e). Taken together, these
results indicate that the methylation machinery of TMS1 gene
includes the Dnmt3b, that one of the survivin gene includes
the Dnmt1 and that the one of caspase-8 gene includes the
cooperation of Dnmt1 and Dnmt3a.
Discussion
Cancer cells are known to harbor aberrant DNA methylation
proﬁles(globalDNAhypomethylationandgene-speciﬁchypo-
or hypermethylation) and defects in apoptotic pathway. In this
study,weobservedthatthelossofapoptosisiscorrelatedwith
the loss of DNA methylation in GBM. At molecular level, the
analysis of a collection of 27 GBM patients revealed that the
unmethylation of bcl-2 gene is the only hallmark associated
with a low level of genome methylation in the one hand and
with a low intra-tumor apoptosis level in the other hand. In
other terms, our study suggests that the unmethylation-
induced overexpression of Bcl-2 is a factor aiding the GBM to
acquiretheapoptosisevasionphenotypeinacontextofglobal
DNA hypomethylation. Except for the methylation status of
bcl-2 gene, we noted that the unmethylation of the bcl-w and
survivin genes is also correlated with a low DNA methylation
level. Besides, there is a strong association between the
methylation status of the bcl-w and bcl-2 genes, which were
correlated in 89% of cases (r¼0.6625, P¼0.0002), whereas
thereisnocorrelation betweenthemethylationstatusofthese
two genes and the methylation status of survivin gene
(r¼ 0.1005, P¼0.6179 and r¼0.2385, P¼0.2309). Thus,
it seems that the methylation machineries controlling the
methylation status of survivin gene in the one hand and the
methylation status of the bcl-w and bcl-2 genes in the other
hand are distinct. This idea is also supported by the fact that
the methylation status of survivin gene is correlated with the
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Cell Death and DiseaseDnmt1 expression, whereas no correlation between the Dnmt
expression and the methylation status of the bcl-w and bcl-2
genes was seen. Further, our observation is consistent with
the one published by Esteve et al.,
21 according to which
Dnmt1 participates in the survivin gene regulation. In addition,
thefactthattheunmethylationofsurvivin,bcl-worbcl-2genes
is correlated with the low level of global DNA methylation
suggests that the methylation machineries regulating the
methylation of these genes is also implicated in the loss of
global DNA methylation, or that the loss/dysfunction of
methylation machineries controlling the level of global DNA
methylationandthemethylationstatusofspeciﬁcgenes,such
as survivin, bcl-w and/or bcl-2, are regulated by shared/
common ethiological factors. As the methylation of caspase-8
gene is correlated with the expression level of Dnmt1 and
Dnmt3a, our data suggest that both Dnmts cooperate to
promote and/or maintain the methylation of caspase-8 gene.
Todate, functional cooperation between Dnmt1a and Dnmt3a
has been already described for DNA and for repetitive
elements, but not for caspase-8 gene.
22–24 Besides, the
cooperation between Dnmt1 and Dnmt3a in the methylation
machinery of caspase-8 gene is one of the ﬁrst examples of
the Dnmt1–Dnmt3a cooperation to methylate a speciﬁc gene,
according to our knowledge. Nevertheless, the cooperation
between de novo and maintenance methyltransferases to
methylate a speciﬁc gene has already been described. Thus,
the literature reports that Dnmt1 and Dnmt3b cooperate to
methylate speciﬁc genes, such as p16
INK4aIgf2, BAG1 or
CXCL12, for example.
25–27 Our work also associates the
Dnmt3b expression level with the methylation status of the
TMS1 gene. Despite the absence of Dnmt identiﬁcation,
Stimsonetal.
28reportthatthemethylation-mediatedsilencing
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Figure 4 Impactofmethylationstatusofapoptotic-associatedgenesonapoptosis.(a)CorrelationbetweentheDEVDaseactivityandthemethylationstatusof theXAF-1,
bcl-2 and bax genes. U, unmethylated; M, methylated; r, correlation coefﬁcient obtained from Pearson’s correlation test; and P, signiﬁcance of a correlation coefﬁcient. (b)
Correlationbetweenthebax
mRNA,bcl-2
mRNAandXAF-1
mRNAexpressionlevelsandthemethylationstatusofthebax,bcl-2andXAF-1genes.U,unmethylated;M,methylated;
r,correlationcoefﬁcientobtainedfromPearson’scorrelationtest;andP,signiﬁcanceofacorrelationcoefﬁcient.(c–e)Impactofinvalidationofthebax,bcl-2orXAF-1geneson
apoptosis in glioma cells. BeGBM, Bax-expressing GBM. Western blots were carried out to conﬁrm the gene invalidations, and DEVDase activity was assessed 24h after
apoptosis induction by etoposide treatment (50mg/ml)
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Cell Death and Diseaseof TMS1 gene is accompanied by histone hypoacetylation,
suggesting that Dnmts that are able to interact with a HDAC
protein can potentially promote the methylation of TMS1
gene. Thus, our data showing the fact that Dnmt3b is a factor
of the TMS1 methylation machinery are consistent with this
idea and also with the fact that Dnmt3b can interact with
HDAC.
29 Further, Supplementary data conﬁrm this point by
showing that the methylation of TMS1 gene in the U87 and
U251 cells was associated with the corecruitment of Dnmt3b,
HDAC1 and Dnmt1 on the TMS1 promoter (Supplementary
Figure S6). Thus, this result obtained by chromatin immuno-
precipitation is interesting for several reasons. First, it
indicates that the TMS1 methylation machinery also impli-
cates a cooperation of Dnmt1 and Dnmt3b despite the
absence of correlation between the expression level of Dnmt1
and the methylation status of TMS1 gene. Second, this result
conﬁrms the idea that Dnmt1 is a factor of the TMS1
methylation machinery.
30 Third, these results, combined with
ourpreviousdata, showthatthe Dnmt1 expressionlevelisnot
a limiting factor for the TMS1 gene methylation machinery in
GBM, contrary to the situation seen in ﬁbroblast, in which
TMS1gene is aberrantly methylatedand silenced in response
to the Dnmt1 overexpression.
30
Thus, all the results presented above provide some bases
to the identiﬁcation of the methylation machineries of
apoptosis-associated genes, for which the Dnmt expression
act as a limiting factor.
With regard to the impact of the eight considered apoptotic-
associated genes on the intra-tumor apoptosis level, our
experiments show that only the methylation status of bcl-2,
bax and XAF-1 genes can inﬂuence the intra-tumor apoptosis
level. Consistent with our previous publications, we here
conﬁrm that bax gene can be methylated on its promoter part
onlyoronitspromoterpartandonitsintronic1region.
7,8Thus,
the ﬁrst methylation proﬁle is correlated with high apoptosis
level in GBM, because it encodes for Baxc expression, an
isoform more apoptogenic than wild-type Bax named Baxa.
The second methylation proﬁle is associated with weak
apoptotic level in GBM, because it promotes the bax silencing
inglioma cells.Moreover, the presence ofseveral methylation
proﬁles of bax gene in GBM is interesting in terms of the
understanding of DNA methylation mechanisms for several
reasons. First, this can suggest the presence of distinct
methylation machineries: one able to promote the methylation
of bax promoter region and a second able to promote the
methylation of bax intronic1 region. Second, according to this
hypothesis, it is potentially possible that the bax
silencing
methylation proﬁle can result from the cooperation between
these two methylation machineries to promote the bax
silencing
methylation proﬁle from the bax
Baxa methylation proﬁle. Third,
the fact that the bax
silencing methylation proﬁle corresponds
to the bax
Baxc methylation proﬁle added with the methylation
of bax intronic1 region can suggest that the bax
silencing
methylation proﬁle can result from methylation of bax
Baxc
methylation proﬁle. A study of these hypotheses applied to a
greater sample size is currently in progress in our lab. As
already discussed above, our analysis reveals a correlation
between the bcl-2 gene methylation status and the level of
intra-tumorapoptosisinGBM.Thispointisprobablyduetothe
fact that the bcl-2 gene methylation status is correlated with
the level of bcl-2 gene expression in our collection of 27 GBM
patients. Indeed, several authors report that the methylation
status of bcl-2 gene did not necessarily correlate with the
relative levels of Bcl-2 expression.
31,32 Thus, these ﬁnding
suggest that the bcl-2 gene methylation may be the one, but
probably not the essential, mechanism regulating the expres-
sion of this gene. Besides, this point is an ongoing subject of
study in our lab. Finally, the presence of correlations between
the XAF-1 gene methylation status, the expression level of
XAF-1 gene and the level of intra-tumor apoptosis in GBM is
consistent with similar observations obtained from several
cancer types such as renal cell carcinoma, human gastric and
colon cancer, for example.
33–35
In conclusion, our study indicates that the aberrant
epigenetic regulation of the apoptosis-associated genes
contributes to the malignant progression of human tumors
byaidingtheappearanceofapoptosisevasionphenotypeand
by conferring poor prognosis in patients with glioma. Although
our data identiﬁed the variations of Dnmt expression asproofs
to explain the presence of 3/8 aberrant DNA methylation
proﬁle of apoptosis-associated genes, we cannot exclude
the fact that the presence of 5/8 aberrant DNA methylation
proﬁle of apoptosis-associated genes is not explained by the
variations in Dnmt expression. This last point introduces the
idea that the Dnmts, despite their central role in the DNA
methylation machinery, work in a network of proteins working
in concert, the characterization of which will be a new step in
the understanding of molecular mechanisms promoting the
resistance of apoptosis in glioma.
Materials and Methods
Patient characteristics. Overall survival was measured from the date of
surgical resection to the death. All patients included in this study had similar
management (complete resection) and similar treatment (temozolomide and
fractionatedradiotherapy).Karnofskyperformancescoresofpatientsareincludedin
the 80–90 range and age is included in the 49–65 years range.
Epigenetic analysis. DNA was extracted by using the QiaAmp DNA mini Kit
(Qiagen, Courtaboeuf, France). The 5mC number was assessed with the
Methylamp Global DNA methylation Quantiﬁcation kit (Euromedex-Epigentek,
Strasbourg, France). The methylation status of apoptotic-associated genes was
determined by MSP, according to the primers designed by using the MethPrimer
38
program and after sodium bisulﬁte conversion (EZ DNA methylation Gold kit, Zymo
research, Orange, CA, USA). MeDIP were performed by using MeDIP kit according
to the manufacturer’s instructions (Diagenode, Evry, France). Primers used in this
study were caspase-8, s: 50-GGTGGAGGTTGCAGTGAG-30, as: 50-TGGA
GTGTTGGTGCTACTGA-30; TMS1, s: 50-CCCCAGTATGTGGAATTGAGG-30, as:
50-TTGCACCAGCGGGTACAGA-30; survivin, s: 50-AGTAGAGACAAGGTTTCACC
G-30, as: 50-GCCCCCTCGACTGCTTT-30.
Western blot. In brief, 50mg of proteins were size fractionated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis. Proteins were transferred onto
nitrocellulose or PVDF membrane. Saturation and blotting were realized by using
SNAP i.d Protein Detection System (Millipore, Molsheim, France). The detection of
proteinswascarriedoutusingECL(AmershamBiosciences,Pantin,France)and/or
SuperSignal west femto maximum sensitivity (Pierce, Thermo Fisher Scientiﬁc,
Brebie ´res, France) chemiluminescence reagents. Bands were quantiﬁed using
Quantity One quantiﬁcation software (BioRad, Marnes-la-coquette, France). Anti-
Bax (Millipore, no. 06-499); anti-Bcl-2 (Epitomics, Euromodex, Mundolsheim,
France, no. 1018-1); anti-actin (Chemicon, Hants, Great Britain, no. MAB1501R);
and anti-XAF-1 (Abcam, Paris, France, no. 17204).
Quantitative PCR. RNA was isolated from cells using trizol. Quantitative PCR
(qPCR) reactions were done in triplicate by using the Multiplex Quantitative
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Cell Death and DiseasePCR system (Mx4000), qPCR Core Reagent kit (Stratagene, Agilent, Masy,
France), according to manufacturer’s instructions, and by using primers speciﬁc for
Bax (F: 50-GCTGTTGGGCTGGATCCAAG-30 and R: 50-TCAGCCCATCTTCTT
CCAGA-30) and Bcl-2 (F: 50-ATGTGTGTGGAGAGCGTCAACC-30 and R: 50-TG
AGCAGAGTCTTCAGAGACAGCC-30). XAF-1
mRNA expression was assessed by
using primers designed by Fong et al.
36 GAPDH was used as housekeeping gene
(F: 50-GTGAAGGTCGGAGTCAACG-30 and R: 50-TGAGGTCAATGAAGGGGTC-30).
Caspase activation assay. Total cell lysis was carried out and protein
concentrations were measured using the Bradford technique. DEVDase activity
was measured using the ﬂuorometric CaspACE Assay System (Promega , Paris,
France) and normalized to the sample protein concentration, as described
previously.
37
Gene invalidation experiments. XAF-1 gene was invalidated by using
XAF-1 siRNA (Santa Cruz, Heildelberg, Germany, sc-37511) according to
manufacturers instructions. Bax gene invalidation was performed as previously
described. The invalidations of the bcl-2, Dnmt1, Dnmt3a and/or Dnmt3b genes
were performed by using the shRNA method and according to the manufacturer’s
instructions (Sigma, Lyon, France).
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